HISTORY OF CURRENT THREAT EPIDEMIOLOGY OF ANTHRAX MICROBIOLOGY PATHOGENESIS AND CLINICAL MANIFESTATIONS DIAGNOSIS VACCINATION THERAPY INFECTION CONTROL DECONTAMINATION AUTHOR/ARTICLE INFORMATION REFERENCES INDEX OF FIGURES AND TABLES Anthrax as a Biological Weapon, 2002 Updated Recommendations for Management

| FULL TEXT | PDF | MEDLINE 64.Mina B, Dym JP, Kuepper F, et al.Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman inNew York City.JAMA.2002;287:858-862.ABSTRACT | FULL TEXT | PDF | MEDLINE 65.Bush LM, Abrams BH, Beall A, Johnson CC.Index case of fatal inhalational anthrax due to bioterrorism in the United States.N Engl J Med.2001;345:1607-1610.MEDLINE 66.Mayer TA, Bersoff-Matcha S, Murphy C, et al.Clinical presentation of inhalational anthrax following bioterrorism exposure.JAMA.2001;286:2549-2553.ABSTRACT | FULL TEXT | PDF | MEDLINE 67.Pile JC, Malone JD, Eitzen EM, Friedlander A.Anthrax as a potential biological warfare agent.Arch Intern Med.1998;158:429-434.ABSTRACT | FULL TEXT | PDF | MEDLINE 68.Kaye E, Kaye K.Fever and rash.In: Eugene Braunwald, Anthony S. Fauci, Kurt J. Isselbacher, et al, eds. Harrison'sTextbook of Medicine. New York, NY: McGraw-Hill; 2001.